Cooper, Dan, Jocelyne Moisan, Belkacem Abdous, and Jean-Pierre Grégoire. “A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA”. Journal of Population Therapeutics and Clinical Pharmacology 15, no. 3 (December 8, 2018). Accessed September 11, 2025. https://jptcp.com/index.php/jptcp/article/view/229.